NAD+ metabolism in health and disease
A good candidate for self-injection is someone who is medically stable, has no bleeding disorder, is not on high-dose blood thinners without medical guidance, has completed an in-clinic training session, and has a reliable sharps container at home
"Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract" Current Pharmaceutical Design, 17(16):1612-1632 "BPC 157 and blood vessels" Current Pharmaceutical Design, 20(7):1121-1125 "Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth" Journal of Orthopaedic Research, 21(6):976-983 "Stable gastric pentadecapeptide BPC 157-NO-system relation" Current Pharmaceutical Design, 20(7):1126-1135 "Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications" Current Neuropharmacology, 14(8):857-865 This product is a chemical raw material intended exclusively for in vitro research, scientific, and analytical applications
Subsequent work ought to standardize outcomes and reporting and use clinically relevant endpoints
That policy was reversed following our involvement and injections were re-instated
Some notable examples include: BPC-157 Epitalon GHK-Cu Thymosin Alpha-1 A lot of these peptides work by supporting cell repair, reducing inflammation, or optimizing hormone release